{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T03:19:11Z","timestamp":1788923951809,"version":"build-2803163510"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12346-8","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:15:43Z","timestamp":1766124943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sensitivity and specificity of dried blood spot samples for hepatitis C virus RNA testing"],"prefix":"10.1186","volume":"26","author":[{"given":"Agnes","family":"Malobela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Amougou-Atsama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Iliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Mugisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Berishvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manana","family":"Sologashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Fajardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Lamoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Mac\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxwell","family":"Chirehwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Njouom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelos","family":"Hatzakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules","family":"Kabahizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude Mambo","family":"Muvunyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Alkhazashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Ivanova","family":"Reipold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"12346_CR1","unstructured":"World Health Organization. Updated recommendations on treatment of adolescents and children with chronic HCV infection, and HCV simplified service delivery and HCV diagnostics [Internet]. World Health Organization. 2022: 155 p. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240052734."},{"issue":"4","key":"12346_CR2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333\u201342.","journal-title":"Hepatology"},{"issue":"4","key":"12346_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2217\/fvl.13.11","volume":"8","author":"M Lemoine","year":"2013","unstructured":"Lemoine M, Nayagam S, Thursz M. Viral hepatitis in resource-limited countries and access to antiviral therapies: current and future challenges. Future Virol. 2013;8(4):371\u201380.","journal-title":"Future Virol"},{"key":"12346_CR4","volume-title":"Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework","author":"E Day","year":"2019","unstructured":"Day E, Hellard M, Treloar C, Bruneau J, Martin NK, \u00d8vrehus A, et al. Hepatitis C elimination among people who inject drugs: challenges and recommendations for action within a health systems framework. Vol. 39. Liver International; 2019."},{"key":"12346_CR5","doi-asserted-by":"crossref","unstructured":"Mehdiyev R, Alikhanova N, Gurbanova E. HIV\/tuberculosis\/hepatitis C virus services for incarcerated populations in Azerbaijan and the Eastern Europe Central Asia region. Curr Opin HIV AIDS. 2019;14.","DOI":"10.1097\/COH.0000000000000513"},{"key":"12346_CR6","doi-asserted-by":"crossref","unstructured":"Mane A, Sacks J, Sharma S, Singh H, Tejada-Strop A, Kamili S, et al. Evaluation of five rapid diagnostic tests for detection of antibodies to hepatitis C virus (HCV): a step towards scale-up of HCV screening efforts in India. PLoS One. 2019;14(1).","DOI":"10.1371\/journal.pone.0210556"},{"key":"12346_CR7","unstructured":"Public Health England; UK Standards for microbiology investigations. Screening for hepatitis C infection. 2017;5(7):1\u201325. Available in: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/634739\/V_5i7.pdf."},{"key":"12346_CR8","unstructured":"World Health Organisation. Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations [Internet]. 2022. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240052390."},{"key":"12346_CR9","doi-asserted-by":"crossref","unstructured":"Smit PW, Sollis KA, Fiscus S, Ford N, Vitoria M, Essajee S, et al. Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One. 2014;9(3).","DOI":"10.1371\/journal.pone.0086461"},{"key":"12346_CR10","doi-asserted-by":"crossref","unstructured":"Lange B, Cohn J, Roberts T, Camp J, Chauffour J, Gummadi N, et al. Diagnostic accuracy of serological diagnosis of hepatitis C and B using dried blood spot samples (DBS): two systematic reviews and meta-analyses. BMC Infect Dis. 2017.","DOI":"10.1186\/s12879-017-2777-y"},{"key":"12346_CR11","doi-asserted-by":"crossref","unstructured":"Carty PG, McCarthy M, O\u2019Neill SM, De Gascun CF, Harrington P, O\u2019Neill M, et al. Laboratory-based testing for hepatitis C infection using dried blood spot samples: a systematic review and meta-analysis of diagnostic accuracy. Rev Med Virol. 2022;32.","DOI":"10.1002\/rmv.2320"},{"key":"12346_CR12","doi-asserted-by":"crossref","unstructured":"Neesgaard B, Ruhwald M, Krarup HB, Weis N. Determination of anti-HCV and quantification of HCV-RNA and IP-10 from dried blood spots sent by regular mail. PLoS One. 2018;13(7).","DOI":"10.1371\/journal.pone.0201629"},{"key":"12346_CR13","doi-asserted-by":"crossref","unstructured":"Practice Guidelines Panel C, Pawlotsky JM, Governing Board Representative E, Negro F, P Members, Aghemo A, et al. EASL recommendations on treatment of hepatitis C: final update of the series q European Association for the study of the liver*. J Hepatol. 2020;73.","DOI":"10.1016\/j.jhep.2020.08.018"},{"key":"12346_CR14","doi-asserted-by":"crossref","unstructured":"Cohen JF, Korevaar DA, Altman DG, Bruns DE, Gatsonis CA, Hooft L, et al. STARD, 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration. BMJ Open. 2016.","DOI":"10.1136\/bmjopen-2016-012799"},{"key":"12346_CR15","unstructured":"Organization WH. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. WHO. 2018."},{"key":"12346_CR16","doi-asserted-by":"crossref","unstructured":"Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis C screening among adults-United States, 2020. MMWR Recomm Rep. 2020.","DOI":"10.15585\/mmwr.rr6902a1"},{"key":"12346_CR17","unstructured":"Lamoury F. Laboratory manual study title short title evaluation DBS for HCV RNA testing [Internet]. 2019. Available from: https:\/\/figshare.com\/articles\/dataset\/Roche_DBS_and_Plasma_Separation_Data_Set_-_HCV_RNA_Detection\/29543879."},{"key":"12346_CR18","unstructured":"World Health Organization. Summary of who prequalification assessment for Abbott RealTime HCV [Internet]. 2021. Available from: https:\/\/extranet.who.int\/prequal\/sites\/default\/files\/whopr_files\/PQDx_0450-027-00_AbbottRealTimeHCV_PR_v3.0.pdf."},{"key":"12346_CR19","unstructured":"Global Health Network. Global Health Training Centre Research ethics. 2025. https:\/\/globalhealthtrainingcentre.tghn.org\/ich-gcp-r3\/."},{"key":"12346_CR20","unstructured":"WHO. Who prequalification of in vitro Diagnostics public report product: Abbott RealTime HCV who reference number: PQDx 0450-027-00 summary of who prequalification assessment for Abbott RealTime HCV [Internet]. WHO PQ Public Report. 2016. Available from: https:\/\/www.who.int\/diagnostics_laboratory\/evaluations\/pq-list\/hcv\/161216_final_amended_report_0257_012_00.pdf."},{"key":"12346_CR21","volume-title":"Summary of who prequalification assessment for Abbott RealTime HCV","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Summary of who prequalification assessment for Abbott RealTime HCV. 2021."},{"key":"12346_CR22","doi-asserted-by":"crossref","unstructured":"Shepherd SJ, Baxter RE, Gunson RN. Evaluation of the Abbott m2000 system for dried blood spot detection of hepatitis C virus RNA. J Clin Virol. 2019;110.","DOI":"10.1016\/j.jcv.2018.10.008"},{"key":"12346_CR23","doi-asserted-by":"crossref","unstructured":"Amougou-Atsama M, Jean Adrien Atangana P, Noah Noah D, Fewou Moundipa P, Pineau P, Njouom R. The role of hepatitis C virus genotypes and core mutations in hepatocellular carcinoma in Cameroon. J Viral Hepat. 2020;27(9).","DOI":"10.1111\/jvh.13303"},{"key":"12346_CR24","doi-asserted-by":"crossref","unstructured":"Njifon AM, Modiyinji AF, Monamele CG, Mbouyap PR, Ngono L, Tagnouokam-Ngoupo PA, et al. A decade-long retrospective study of hepatitis C virus genetic diversity in Cameroon, 2013-2023. presence of a high proportion of unsubtypable and putative recombinant HCV strains. Arch Virol. 2024;169(10).","DOI":"10.1007\/s00705-024-06124-1"},{"key":"12346_CR25","doi-asserted-by":"crossref","unstructured":"Wiesmann F, Naeth G, Sarrazin C, Berger A, Kaiser R, Ehret R, et al. Variation analysis of six HCV viral load assays using low viremic HCV samples in the range of the clinical decision points for HCV protease inhibitors. Med Microbiol Immunol. 2015.","DOI":"10.1007\/s00430-014-0364-z"},{"key":"12346_CR26","doi-asserted-by":"crossref","unstructured":"Li W, Lee MS, Li W, Lee MS. Dried blood spots: applications and techniques. 2014;9781118054697.","DOI":"10.1002\/9781118890837"},{"key":"12346_CR27","doi-asserted-by":"crossref","unstructured":"Bargain P, Heslan C, Thibault V, Pronier C. Combined use of dried blood spot and rapid molecular systems: a robust solution to monitor hepatitis B virus infection with potential for resource-limited countries. J Virol Methods. 2020;283.","DOI":"10.1016\/j.jviromet.2020.113908"},{"key":"12346_CR28","doi-asserted-by":"crossref","unstructured":"Tejada-Strop A, Drobeniuc J, Mixson-Hayden T, Forbi JC, Le NT, Li L, et al. Disparate detection outcomes for anti-HCV IgG and HCV RNA in dried blood spots. J Virol Methods. 2015.","DOI":"10.1016\/j.jviromet.2014.10.018"},{"key":"12346_CR29","unstructured":"Abbott Molecular Diagnostics. Infectious disease, oncology and genetics, 2021 global product catalog [Internet]. Available from: https:\/\/www.molecular.abbott\/content\/dam\/add\/molecular\/offerings\/explore-product-catalog\/AMD.14681%20Global%20Catalog_V36_reduced%20size.pdf?utm."},{"key":"12346_CR30","unstructured":"Clinton Health Access initiative (CHAI). HCV market intelligence report 2021 and preliminary HBV market insights [Internet]. Available from: https:\/\/chai19.wpenginepowered.com\/wp-content\/uploads\/2021\/08\/Hepatitis-C-Market-Report_2021-FINAL-1.pdf."},{"key":"12346_CR31","volume-title":"Diagnostic accuracy of point-of-care HCV viral load assays for HCV diagnosis: a systematic review and meta-analysis","author":"W Tang","year":"2022","unstructured":"Tang W, Tao Y, Fajardo E, Reipold EI, Chou R, Tucker JD, et al. Diagnostic accuracy of point-of-care HCV viral load assays for HCV diagnosis: a systematic review and meta-analysis. Diagnostics. 2022;12."},{"key":"12346_CR32","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Campreci\u00f3s J, Rando-Segura A, Buti M, Rodrigo-Vel\u00e1squez F, Riveiro-Barciela M, Barreira-D\u00edaz A, et al. Reflex viral load testing in dried blood spots generated by plasma separation card allows the screening and diagnosis of chronic viral hepatitis. J Virol Methods. 2021;289.","DOI":"10.1016\/j.jviromet.2020.114039"},{"key":"12346_CR33","doi-asserted-by":"crossref","unstructured":"Soulier A, Poiteau L, Rosa I, H\u00e9zode C, Roudot-Thoraval F, Pawlotsky JM, et al. Dried blood spots: a tool to ensure broad access to hepatitis C screening, diagnosis, and treatment monitoring. J Infect Dis. 2016.","DOI":"10.1093\/infdis\/jiv423"},{"key":"12346_CR34","doi-asserted-by":"crossref","unstructured":"Coats JT, Dillon JF. The effect of introducing point-of-care or dried blood spot analysis on the uptake of hepatitis C virus testing in high-risk populations: a systematic review of the literature. Int J Drug Policy. 2015;26.","DOI":"10.1016\/j.drugpo.2015.05.001"},{"key":"12346_CR35","doi-asserted-by":"crossref","unstructured":"Prabdial-Sing N, Gaelejwe L, Makhathini L, Thaver J, Manamela MJ, Malfeld S, et al. The performance of hepatitis C virus (HCV) antibody point-of-care tests on oral fluid or whole blood and dried blood spot testing for HCV serology and viral load among individuals at higher risk for HCV in South Africa. Health Sci Rep. 2021;4(1).","DOI":"10.1002\/hsr2.229"},{"key":"12346_CR36","unstructured":"World Health Organization. Recommendations and guidance on hepatitis C virus self-testing. World Health Organ; 2021. p. 20."},{"key":"12346_CR37","doi-asserted-by":"crossref","unstructured":"Prinsenberg T, Rebers S, Boyd A, Zuure F, Prins M, Van Der Valk M, et al. Dried blood spot self-sampling at home is a feasible technique for hepatitis C rna detection. PLoS One. 2020.","DOI":"10.1371\/journal.pone.0231385"},{"key":"12346_CR38","doi-asserted-by":"crossref","unstructured":"Raugi DN, Nixon RS, Leong S, Faye K, Diatta JP, Sall F, et al. HIV-2 drug resistance genotyping from dried blood spots. J Clin Microbiol. 2021;59(1).","DOI":"10.1128\/JCM.02303-20"},{"key":"12346_CR39","doi-asserted-by":"crossref","unstructured":"Greenman J, Roberts T, Cohn J, Messac L. Dried blood spot in the genotyping, quantification and storage of HCV RNA: a systematic literature review. J Viral Hepat. 2015.","DOI":"10.1111\/jvh.12345"},{"key":"12346_CR40","doi-asserted-by":"crossref","unstructured":"Easterbrook PJ. Who to test and how to test for chronic hepatitis C infection - 2016 who testing guidance for low- and middle-income countries. J Hepatol. 2016;65.","DOI":"10.1016\/j.jhep.2016.08.002"},{"key":"12346_CR41","doi-asserted-by":"crossref","unstructured":"Peeling RW, Boeras DI, Marinucci F, Easterbrook P. The future of viral hepatitis testing: innovations in testing technologies and approaches. BMC Infect Dis. 2017.","DOI":"10.1186\/s12879-017-2775-0"},{"key":"12346_CR42","doi-asserted-by":"crossref","unstructured":"Chevaliez S. Strategies for the improvement of HCV testing and diagnosis. Expert Rev Anti-Infect Ther. 2019;17.","DOI":"10.1080\/14787210.2019.1604221"},{"key":"12346_CR43","volume-title":"Current and future diagnostics for hepatitis C virus infection","author":"H Zilouchian","year":"2025","unstructured":"Zilouchian H, Faqah O, Kabir MA, Gross D, Pan R, Shaifman S, et al. Current and future diagnostics for hepatitis C virus infection. Vol. 13. Chemosensors. Multidisciplinary Digital Publishing Institute (MDPI); 2025."},{"key":"12346_CR44","doi-asserted-by":"crossref","unstructured":"Applegate TL, Fajardo E, Sacks JA. Hepatitis C virus diagnosis and the holy grail. Infect Dis Clin North Am. 2018;32.","DOI":"10.1016\/j.idc.2018.02.010"},{"key":"12346_CR45","doi-asserted-by":"crossref","unstructured":"Nichols BE, Girdwood SJ, Shibemba A, Sikota S, Gill CJ, Mwananyanda L, et al. Cost and impact of dried blood spot versus plasma separation card for scale-up of viral load testing in resource-limited settings. Clin Infect Dis. 2020;70(6).","DOI":"10.1093\/cid\/ciz338"},{"key":"12346_CR46","doi-asserted-by":"crossref","unstructured":"Duchesne L, Hejblum G, Njouom R, Kane CT, Toni T, Moh R, et al. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa. PLoS One. 2020;15(8 August).","DOI":"10.1371\/journal.pone.0238035"},{"key":"12346_CR47","doi-asserted-by":"crossref","unstructured":"Carrington N, Conway A, Grebely J, Starr M, Catlett B, Stevens A, et al. Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot. BMC Infect Dis. 2024;24(1).","DOI":"10.1186\/s12879-024-08989-8"},{"key":"12346_CR48","doi-asserted-by":"crossref","unstructured":"Nicol\u00e1s-P\u00e9rez D, Morales DE, Castilla-Rodr\u00edguez I, Guti\u00e9rrez F, Flores FD, de Vera A, et al. Hepatitis C virus infection screening reduces mortality and is cost-effective independently of the intervention test. Rev Esp Enferm Dig. 2022;114(12).","DOI":"10.17235\/reed.2022.8609\/2022"},{"key":"12346_CR49","doi-asserted-by":"crossref","unstructured":"Shawa IT, Sheridan DA, Felmlee DJ, Cramp ME. Lipid interactions influence hepatitis C virus susceptibility and resistance to infection. Clin Liver Dis. 2017;10.","DOI":"10.1002\/cld.643"},{"key":"12346_CR50","doi-asserted-by":"crossref","unstructured":"Sheridan DA, Shawa IT, Thomas EL, Felmlee DJ, Bridge SH, Neely D, et al. Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis. Sci Rep. 2022;12(1).","DOI":"10.1038\/s41598-022-09588-w"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12346-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12346-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:53:17Z","timestamp":1769172797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12346-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12346"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12346-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by institutional review boards in Cameroon, Le Comit\u00e9 National d\u2019Ethique pour la Recherche en Sant\u00e9 Humaine (CNERSH) - (N\u00b02019\/04\/1157\/CE\/CNERSH\/SP), Georgia, National Centre for Disease Control and Public Health Institutional Review Board - (N\u00b08160\u20132\/1), Greece, The Institutional Review Board of the Hellenic Scientific Society for the Study of AIDS and Sexually Transmitted Diseases (EEEEAIDS) - (Protocol N\u00b0121) and Rwanda by the Rwanda National Ethics Committee (RNEC) - (N\u00b0121\/RNEC\/2020 and N\u00b0328\/RNEC\/2019).Informed consent was obtained from all participants involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}